Abstract

Impaired vigilance is a core cognitive deficit in schizophrenia and may serve as an endophenotype (i.e., mark genetic liability). We used a continuous performance task with perceptually degraded stimuli in schizophrenia patients (N = 48), bipolar disorder patients (N = 26), first-degree biological relatives of schizophrenia patients (N = 55) and bipolar disorder patients (N = 28), as well as healthy controls (N = 68) to clarify whether previously reported vigilance deficits and abnormal neural functions were indicative of genetic liability for schizophrenia as opposed to a generalized liability for severe psychopathology. We also examined variation in the Catechol-O-methyltransferase gene to evaluate whether brain responses were related to genetic variation associated with higher-order cognition. Relatives of schizophrenia patients had an increased rate of misidentification of nontarget stimuli as targets when they were perceptually similar, suggestive of difficulties with contour perception. Larger early visual responses (i.e., N1) were associated with better task performance in patients with schizophrenia consistent with enhanced N1 responses reflecting beneficial neural compensation. Additionally, reduced N2 augmentation to target stimuli was specific to schizophrenia. Both patients with schizophrenia and first-degree relatives displayed reduced late cognitive responses (P3b) that predicted worse performance. First-degree relatives of bipolar patients exhibited performance deficits, and displayed aberrant neural responses that were milder than individuals with liability for schizophrenia and dependent on sex. Variation in the Catechol-O-methyltransferase gene was differentially associated with P3b in schizophrenia and bipolar groups. Poor vigilance in schizophrenia is specifically predicted by a failure to enhance early visual responses, weak augmentation of mid-latency brain responses to targets, and limited engagement of late cognitive responses that may be tied to genetic variation associated with prefrontal dopaminergic availability. Experimental results illustrate specific neural functions that distinguish schizophrenia from bipolar disorder and provides evidence for a putative endophenotype that differentiates genetic liability for schizophrenia from severe mental illness more broadly.

Highlights

  • Impaired vigilance represents a core cognitive deficit in schizophrenia, with evidence suggesting that it may mark genetic liability for the disorder

  • We examined a single nucleotide polymorphisms (SNPs) of Catechol-O-methyltransferase (COMT) gene to evaluate whether brain responses elicited by the degraded stimulus continuous performance task (DS-CPT) may be associated with a select aspect of genetic variation that has been related to both schizophrenia and bipolar disorder (Docherty & Sponheim, 2008; Goghari & Sponheim, 2008; Silberschmidt & Sponheim, 2008; Venables et al, 2009)

  • A MANOVA examining the N1 component in healthy controls (HC), SZ and SZRel at O1 and O2 revealed a main effect of task (F(1,161) = 19.60, p

Read more

Summary

Introduction

Impaired vigilance represents a core cognitive deficit in schizophrenia, with evidence suggesting that it may mark genetic liability for the disorder (i.e., be an endophenotype; Cornblatt & Malhotra, 2001; Gottesman & Gould, 2003; Green et al, 2004). We examined a single nucleotide polymorphisms (SNPs) of Catechol-O-methyltransferase (COMT) gene to evaluate whether brain responses elicited by the DS-CPT may be associated with a select aspect of genetic variation that has been related to both schizophrenia and bipolar disorder (Docherty & Sponheim, 2008; Goghari & Sponheim, 2008; Silberschmidt & Sponheim, 2008; Venables et al, 2009). Do patients with bipolar disorder and their first-degree relatives share aberrant middle (i.e. N2) and late (i.e. P3b) latency posterior brain potentials seen in patients with schizophrenia and their relatives?; 3) Does variation in the COMT gene relate to neural functions implicated in higher-order cognition, and does this relationship differentiate genetic liability for schizophrenia from bipolar disorder?. We examined associations between ERPs and performance indices of the DS-CPT with symptomatology, medication dosage, and estimated IQ to investigate relationships with aspects of disease expression

Methods
Task Performance
ERP Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call